Thus, the identification of either increased numbers of T regulatory cells or CD4-positive T cells with CD7 and CD45 overexpression may serve as a useful adjunct or screening test for CHL in the proper clinical context. The gene discussed is CD7; the disease is classic Hodgkin lymphoma.